Abstract
Brain tissue (hippocampus and cerebral cortex) from Alzheimer's disease and control individuals sampled from Eastern Canada and the United Kingdom were analyzed for Ag, Al, As, B, Br, Ca, Cd, Co, Cr, Cs, Cu, Fe, Hg, I, K, La, Mg, Mn, Mo, Ni, Rb, S, Sb, Sc, Se, Si, Sn, Sr, Ti, V and Zn. Neutron activation analysis (thermal and prompt gamma-ray) methods were used. Highly significant differences (probability less than 0.005) for both study areas were shown between Alzheimer's diesease (AD) and control (C) individuals: AD>C for Al, Br, Ca and S, and AD<C for Se, V and Zn. Aluminium content of brain tissue ranged from 3.605 to 21.738 μg/g d.w. (AD) and 0.379 to 4.768, μg/g d.w. (C). No statistical evidence of aluminium accumulation with age was noted. Possible zinc deficiency (specially for hippocampol tissue), was observed with zinc ranges of 31.42 to 57.91 μg/g d.w. (AD) and 37.31 to 87.10 μg/g d.w. (C), for Alzheimer's disease patients.
Similar content being viewed by others
References
I. E. DREOSTI, R. H. SMITH, Neurobiology of the Trace Elements, Vol. 2, Neurotoxicology and Neuropharmacology, Humana Press, Clifton, New Jersey, 1983, p. 260.
D. R. CRAPPER, S. S. KRISHNAN, S. QUITTKAT, Brain, 99 (1976) 67.
D. P. PERL, A. R. BRODY, Science, 208 (1980) 297.
E. J. UNDERWOOD, Trace Elements in Human and Animal Nutrition, Academic Press, New York, 1977.
T. NIKAIDO, J. AUSTIN, L. TRUEB, R. RINEHART, Arch. Neurol., 27 (1972) 549.
D. G. Mac INNES, H. W. READING, A. I. M. GLEN, Micro-detection of fluorescent material in brain sections, Chapter 11, Alzheimer's Disease. Early Recognition of Potentially Reversible Deficits, A. I. M. GLEN, L. J. WHALLEY (Eds.), Churchill Livingstone, Edinburgh, London, 1979.
N. I. WARD, D. E. RYAN, Anal. Chim. Acta, 105 (1979) 185.
N. I. WARD, The Determination of Boron in Biological Materials by Neutron Irradiation and Prompt Gamma-ray Spectrometry, International Symposium on Nuclear Analytical Chemistry, Halifax, Nova Scotia, Canada, 1985.
N. I. WARD, B. PIM, Biol. Trace Element Res., 6 (1984) 469.
L. A. CURRIE, Anal. Chem., 40 (1968) 586.
D. R. CRAPPER, S. S. DRISHNAN, A. J. DALTON, Science, 180 (1973) 511.
D. R. CRAPPER, McLACHIAN, S. S. KRISHNAN, S. QITTKAT, U. De BONI, Neurotoxicol., 1 (1980) 25.
J. R. Mc DERMOTT, A. I. SMITH, K. IQBAL, H. M. WISNIEWSKI, Lancet, 2 (1977) 710.
J. R. McDERMOTT, A. I. SMITH, K. IQBAL, H. M. WESNIEWSKI, Neurol., 29 (1979) 809.
N. A. LARSEN, H. PAKKENBERG, E. DAMSGAARD, K. HEYDORN, J. Neurol. Sci., 42 (1979) 407.
R. E. NEWHAM, Boron is essential — It Corrects and Prevents Arthritis, Conference of the New Zealand Trace Element Group, Massey University, Palmerston North, New Zealand, Aug. 1984.
A. SAHGAL, Trends Neurosci., 3 (1980) 116.
I. L. CRAWFORD, J. D. CONNOR, Nature, 244 (1973) 442.
J. STORM-MATHISEN, Glutamate in hippocamal pathways, in: G. Di GHIARA, G. L. GESSA (Eds), Glutamate as a Neurotransmitter, Raven Press, New York, 1981, p. 43.
I. E. DREOSTI, S. J. MANUEL, R. A. BUCKLEY, F. J. FRASER, I. R. RECORD, Life Sci., 28 (1981) 2133.
R. I. HENKIN, B. PATTEN, P. K. RE, D. A. BRONZERT, Arch. Neurol., 32 (1975) 745.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ward, N.I., Mason, J.A. Neutron activation analysis techniques for identifying elemental status in Alzheimer's disease. Journal of Radioanalytical and Nuclear Chemistry, Articles 113, 515–526 (1987). https://doi.org/10.1007/BF02050527
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02050527